Practice Guideline Update: Pharmacologic Treatment for Pediatric Migraine Prevention
Practice Guideline, August 2019
Read Published ArticleThis guideline systematically evaluates new evidence to answer the following clinical question: In children and adolescents with migraines, do preventive pharmacologic treatments, with or without cognitive behavioral therapy (CBT), compared with placebo, reduce headache frequency?
Reaffirmed on October 22, 2022.
Endorsed by the American Academy of Pediatrics and the Child Neurology Society.
Clinician Tools and Materials
Clinician Summary
Download a PDF summary of this guideline product
Full-length Version
Download a PDF of the full guideline product, including full details of the methodology and data analysis
好色先生al Materials
Other resources related to this guideline
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.
Press Release
Download the AAN press release about this guideline product